Micah Ostrowski, Yeonjung Jo, Georges Gebrael, Zeynep Irem Ozay, Varun Nandakumar, Chadi Hage Chehade, Gabriel Hooper, Richard Tanner Hardy, Krishnam Goel, Patrick Campbell, Roberto H Nussenzveig, Haoran Li, Vinay Mathew Thomas, Benjamin L. Maughan, Umang Swami, Neeraj Agarwal. "Real-world comparative effectiveness of first-line (1L) cabozantinib (C) versus cabozantinib with nivolumab (C+N) in patients (pts) with metastatic papillary renal cell carcinoma (mPRCC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.461